These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68. Nonoxynol 9 as an additive therapy in metronidazole-resistant cases of vaginal trichomoniasis. El Bassiouni SO; Riad RM J Egypt Soc Parasitol; 2005 Aug; 35(2):551-62. PubMed ID: 16083067 [TBL] [Abstract][Full Text] [Related]
69. Efficacy of two plant extracts against vaginal trichomoniasis. El-Sherbini GT; El Gozamy BR; Abdel-Hady NM; Morsy TA J Egypt Soc Parasitol; 2009 Apr; 39(1):47-58. PubMed ID: 19530609 [TBL] [Abstract][Full Text] [Related]
70. Management of recalcitrant Trichomonas vaginalis in pregnancy: a case report. Tayal S Int J STD AIDS; 2016 Feb; 27(2):147-8. PubMed ID: 25829518 [TBL] [Abstract][Full Text] [Related]
71. Interventions for treating trichomoniasis in women. Forna F; Gülmezoglu AM Cochrane Database Syst Rev; 2003; (2):CD000218. PubMed ID: 12804391 [TBL] [Abstract][Full Text] [Related]
72. Efficacy and tolerance of metronidazole and miconazole nitrate in treatment of vaginitis. Peixoto F; Camargos A; Duarte G; Linhares I; Bahamondes L; Petracco A Int J Gynaecol Obstet; 2008 Sep; 102(3):287-92. PubMed ID: 18603245 [TBL] [Abstract][Full Text] [Related]
73. Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative. Bitencourt FG; de Brum Vieira P; Meirelles LC; Rigo GV; da Silva EF; Gnoatto SCB; Tasca T Parasitol Res; 2018 May; 117(5):1573-1580. PubMed ID: 29572567 [TBL] [Abstract][Full Text] [Related]
74. Nimorazole compared with metronidazole in the treatment of vaginal trichomoniasis. Tinkler AE Practitioner; 1974 Jan; 212(267):115-9. PubMed ID: 4591199 [No Abstract] [Full Text] [Related]
75. Novel metronidazole-chalcone conjugates with potential to counter drug resistance in Trichomonas vaginalis. Anthwal A; Rajesh UC; Rawat MS; Kushwaha B; Maikhuri JP; Sharma VL; Gupta G; Rawat DS Eur J Med Chem; 2014 May; 79():89-94. PubMed ID: 24727243 [TBL] [Abstract][Full Text] [Related]
76. The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population. Abdel-Magied AA; El-Kholya EI; Abou El-Khair SM; Abdelmegeed ES; Hamoudaa MM; Mohamed SA; El-Tantawy NL Parasitol Res; 2017 Nov; 116(11):3125-3130. PubMed ID: 28956167 [TBL] [Abstract][Full Text] [Related]
77. Flunidazole--a new drug for systemic treatment of urogenital trichomoniasis. Pereyra AJ; Nelson RM; Ludders DJ Am J Obstet Gynecol; 1972 Apr; 112(7):963-6. PubMed ID: 4557646 [No Abstract] [Full Text] [Related]
78. [Comparative study for the evaluation of the efficacy and safety of metronidazole and secnidazole in the treatment of vaginal trichomoniasis]. Buitrón García Figueroa R; Gonzalo Butrón López F; Oropez Rechy G; Romero-Cabello R Ginecol Obstet Mex; 1997 Nov; 65():487-91. PubMed ID: 9441152 [TBL] [Abstract][Full Text] [Related]
79. Treatment of trichomoniasis with metronidazole rectal suppositories. Panja SK Br J Vener Dis; 1982 Aug; 58(4):257-8. PubMed ID: 7104657 [TBL] [Abstract][Full Text] [Related]
80. [Microbiological evaluation of the effectiveness of gynalgin in the treatment of vaginitis]. Sikorski R; Hencner Z; Gliński Z; Wawrzkiewicz K; Radomański T; Milart P; Paszkowski T; Skrzypczak W; Sławiński P; Maruszak E Wiad Lek; 1992 Apr; 45(7-8):263-9. PubMed ID: 1462586 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]